Acute Intermittent Porphyria
Overview and clinical definition are open. Full Step 1 details unlock with a plan.
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Acute Intermittent Porphyria is a rare genetic disorder that affects the body's ability to produce heme, an important component of red blood cells. It primarily impacts the nervous system, causing episodes of severe abdominal pain, muscle weakness, and neurological symptoms such as confusion or seizures. These attacks can be triggered by certain medications, stress, or hormonal changes. The condition involves a buildup of toxic substances in the body that interfere with normal nerve function. People with this disorder may experience recurring episodes that can be life-threatening if not recognized and managed properly. The symptoms often come and go, making diagnosis challenging. Understanding the role of heme synthesis is key to grasping how this disease affects health.
Clinical Definition
Acute intermittent porphyria (AIP) is an autosomal dominant, low-penetrance hepatic porphyria caused by reduced hydroxymethylbilane synthase (HMBS; porphobilinogen deaminase) activity. This cytosolic enzyme joins four PBG molecules into hydroxymethylbilane in the third step of heme synthesis. Increased hepatic ALAS1 activity can overwhelm the partial block, raising ALA and PBG. ALA is strongly implicated in nerve injury, although the full mechanism is unresolved. Attacks combine severe abdominal pain, autonomic dysfunction and neuropsychiatric or motor findings; respiratory paralysis and seizures are serious complications. AIP does not characteristically cause photosensitivity.